Europe Antiplatelet Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, and Injectable), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

The Europe Antiplatelet Market would witness market growth of 4.5% CAGR during the forecast period (2023-2030). In the year 2020, the Europe market's volume surged to 105.4 million Units, showcasing a growth of 3.3% (2019-2022).

The accessibility and availability of the healthcare infrastructure also influence the demand for antiplatelet medications. In addition, several nations have developed healthcare systems with modern hospitals, pharmacies, and other healthcare facilities that can detect and treat cardiovascular illnesses better. Access to adequate healthcare services enables patients to receive appropriate prescriptions and follow-up care, driving the demand for antiplatelet medications. The increasing geriatric population also contributes to market expansion. Due to the increased risk of cardiovascular disease and its complications in older persons, there is a higher demand for antiplatelet medications to prevent thrombotic events, which is anticipated to support the expansion of the antiplatelet market. The market growth is expected to be driven by high growth potential in untapped, emerging markets due to improved healthcare infrastructure, rising unmet healthcare needs, and increasing prevalence of cardiovascular diseases.

To support the market expansion, pharmaceutical companies are spending on research and development to create new and enhanced antiplatelet drugs. Furthermore, introducing more potent antiplatelet agents, like P2Y12 receptor inhibitors such as prasugrel and ticagrelor, has afforded clinicians a greater variety of treatment options. Continuous innovation and the development of newer, more effective antiplatelet pharmaceuticals contribute to the expansion of the market. The demand for better healthcare services is increasing, the government is making significant investments to upgrade the healthcare infrastructure, and the medical industry is developing rapidly in emerging economies, supporting market growth. As a result, the healthcare industry in emerging economies is also expanding significantly.

According to Government of UK, the average age surpassed 40 for the first time in the middle of 2014. By 2040, nearly one in seven individuals will be over 75. It is anticipated that 1.42 million more households will be headed by someone aged 85 or older by 2037, a 161% increase over 25 years. The proportion of the working-age population between the ages of 50 and the state pension age is expected to rise from 26% in 2012 to 34% in 2050, a rise of over 5.5 million people. Aging is a well-established risk factor for cardiovascular diseases (CVDs), including coronary artery disease, stroke, and peripheral artery disease. Therefore, the region presents lucrative growth prospects for the market in the coming years.

The Germany market dominated the Europe Antiplatelet Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $343.9 Million by 2030. The UK market is exhibiting a CAGR of 3.6% during (2023 - 2030). Additionally, The France market would experience a CAGR of 5.2% during (2023 - 2030).

Based on Route of Administration, the market is segmented into Oral, and Injectable. Based on Drug Class, the market is segmented into Adenosine diphosphate (ADP) Receptor Inhibitors, Irreversible Inhibitors Cyclooxygenase, and Others. Based on Distribution Channel, the market is segmented into Drug store & Retail Pharmacies, Hospital Pharmacies, and Online Providers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Antiplatelet Market will Hit $5.1 Billion by 2030, at a CAGR of 4.7%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cipla Limited, Glenmark Pharmaceuticals Limited, Bayer AG, AstraZeneca PLC, Daiichi Sankyo Company, Limited, Eli Lilly And Company, Otsuka Pharmaceutical Co., Ltd., Sanofi S.A. , Lupin Limited and Chiesi Farmaceutici S.p.A.

Scope of the Study

Market Segments Covered in the Report:

By Route of Administration (Volume, Million Units, USD Million, 2019-2030)

• Oral
• Injectable

By Drug Class (Volume, Million Units, USD Million, 2019-2030)

• Adenosine diphosphate (ADP) Receptor Inhibitors
• Irreversible Inhibitors Cyclooxygenase
• Others

By Distribution Channel (Volume, Million Units, USD Million, 2019-2030)

• Drug store & Retail Pharmacies
• Hospital Pharmacies
• Online Providers

By Country (Volume, Million Units, USD Million, 2019-2030)

• Russia
• France
• Germany
• UK
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Cipla Limited
• Glenmark Pharmaceuticals Limited
• Bayer AG
• AstraZeneca PLC
• Daiichi Sankyo Company, Limited
• Eli Lilly And Company
• Otsuka Pharmaceutical Co., Ltd.
• Sanofi S.A.
• Lupin Limited
• Chiesi Farmaceutici S.p.A

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Antiplatelet Market, by Route of Administration
1.4.2 Europe Antiplatelet Market, by Drug Class
1.4.3 Europe Antiplatelet Market, by Distribution Channel
1.4.4 Europe Antiplatelet Market, by Country
1.5 Methodology for the research

Chapter 2. Market At a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis

Chapter 4. Europe Antiplatelet Market by Route of Administration
4.1 Europe Oral Market by Country
4.2 Europe Injectable Market by Country

Chapter 5. Europe Antiplatelet Market by Drug Class
5.1 Europe Adenosine diphosphate (ADP) Receptor Inhibitors Market by Country
5.2 Europe Irreversible Inhibitors Cyclooxygenase Market by Country
5.3 Europe Others Market by Country

Chapter 6. Europe Antiplatelet Market by Distribution Channel
6.1 Europe Drug store & Retail Pharmacies Market by Country
6.2 Europe Hospital Pharmacies Market by Country
6.3 Europe Online Providers Market by Country

Chapter 7. Europe Antiplatelet Market by Country
7.1 Germany Antiplatelet Market
7.1.1 Germany Antiplatelet Market by Route of Administration
7.1.2 Germany Antiplatelet Market by Drug Class
7.1.3 Germany Antiplatelet Market by Distribution Channel
7.2 UK Antiplatelet Market
7.2.1 UK Antiplatelet Market by Route of Administration
7.2.2 UK Antiplatelet Market by Drug Class
7.2.3 UK Antiplatelet Market by Distribution Channel
7.3 France Antiplatelet Market
7.3.1 France Antiplatelet Market by Route of Administration
7.3.2 France Antiplatelet Market by Drug Class
7.3.3 France Antiplatelet Market by Distribution Channel
7.4 Russia Antiplatelet Market
7.4.1 Russia Antiplatelet Market by Route of Administration
7.4.2 Russia Antiplatelet Market by Drug Class
7.4.3 Russia Antiplatelet Market by Distribution Channel
7.5 Spain Antiplatelet Market
7.5.1 Spain Antiplatelet Market by Route of Administration
7.5.2 Spain Antiplatelet Market by Drug Class
7.5.3 Spain Antiplatelet Market by Distribution Channel
7.6 Italy Antiplatelet Market
7.6.1 Italy Antiplatelet Market by Route of Administration
7.6.2 Italy Antiplatelet Market by Drug Class
7.6.3 Italy Antiplatelet Market by Distribution Channel
7.7 Rest of Europe Antiplatelet Market
7.7.1 Rest of Europe Antiplatelet Market by Route of Administration
7.7.2 Rest of Europe Antiplatelet Market by Drug Class
7.7.3 Rest of Europe Antiplatelet Market by Distribution Channel

Chapter 8. Company Profiles
8.1 Cipla Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Glenmark Pharmaceuticals Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals:
8.2.6 SWOT Analysis
8.3 Bayer AG
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 AstraZeneca PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Daiichi Sankyo Company, Limited
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Product and Services and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.6 SWOT Analysis
8.6 Eli Lilly And Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Otsuka Pharmaceutical Co., Ltd.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Lupin Limited
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Chiesi Farmaceutici S.p.A
8.10.1 Company Overview
8.10.2 SWOT Analysis

TABLE 1 Europe Antiplatelet Market, 2019 - 2022, USD Million
TABLE 2 Europe Antiplatelet Market, 2023 - 2030, USD Million
TABLE 3 Europe Antiplatelet Market, 2019 - 2022, Million Units
TABLE 4 Europe Antiplatelet Market, 2023 - 2030, Million Units
TABLE 5 Europe Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 6 Europe Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 7 Europe Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 8 Europe Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 9 Europe Oral Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Oral Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe Oral (strip of 10) Market by Country, 2019 - 2022, Million Units
TABLE 12 Europe Oral (strip of 10) Market by Country, 2023 - 2030, Million Units
TABLE 13 Europe Injectable Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Injectable Market by Country, 2023 - 2030, USD Million
TABLE 15 Europe Injectable Market by Country, 2019 - 2022, Million Units
TABLE 16 Europe Injectable Market by Country, 2023 - 2030, Million Units
TABLE 17 Europe Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 18 Europe Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 19 Europe Adenosine diphosphate (ADP) Receptor Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Adenosine diphosphate (ADP) Receptor Inhibitors Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Irreversible Inhibitors Cyclooxygenase Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Irreversible Inhibitors Cyclooxygenase Market by Country, 2023 - 2030, USD Million
TABLE 23 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 26 Europe Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 27 Europe Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 28 Europe Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 29 Europe Drug store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 30 Europe Drug store & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 31 Europe Drug store & Retail Pharmacies Market by Country, 2019 - 2022, Million Units
TABLE 32 Europe Drug store & Retail Pharmacies Market by Country, 2023 - 2030, Million Units
TABLE 33 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 34 Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 35 Europe Hospital Pharmacies Market by Country, 2019 - 2022, Million Units
TABLE 36 Europe Hospital Pharmacies Market by Country, 2023 - 2030, Million Units
TABLE 37 Europe Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 38 Europe Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 39 Europe Online Providers Market by Country, 2019 - 2022, Million Units
TABLE 40 Europe Online Providers Market by Country, 2023 - 2030, Million Units
TABLE 41 Europe Antiplatelet Market by Country, 2019 - 2022, USD Million
TABLE 42 Europe Antiplatelet Market by Country, 2023 - 2030, USD Million
TABLE 43 Europe Antiplatelet Market by Country, 2019 - 2022, Million Units
TABLE 44 Europe Antiplatelet Market by Country, 2023 - 2030, Million Units
TABLE 45 Germany Antiplatelet Market, 2019 - 2022, USD Million
TABLE 46 Germany Antiplatelet Market, 2023 - 2030, USD Million
TABLE 47 Germany Antiplatelet Market, 2019 - 2022, Million Units
TABLE 48 Germany Antiplatelet Market, 2023 - 2030, Million Units
TABLE 49 Germany Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 50 Germany Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 51 Germany Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 52 Germany Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 53 Germany Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 54 Germany Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 55 Germany Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 56 Germany Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 57 Germany Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 58 Germany Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 59 UK Antiplatelet Market, 2019 - 2022, USD Million
TABLE 60 UK Antiplatelet Market, 2023 - 2030, USD Million
TABLE 61 UK Antiplatelet Market, 2019 - 2022, Million Units
TABLE 62 UK Antiplatelet Market, 2023 - 2030, Million Units
TABLE 63 UK Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 64 UK Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 65 UK Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 66 UK Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 67 UK Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 68 UK Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 69 UK Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 UK Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 71 UK Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 72 UK Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 73 France Antiplatelet Market, 2019 - 2022, USD Million
TABLE 74 France Antiplatelet Market, 2023 - 2030, USD Million
TABLE 75 France Antiplatelet Market, 2019 - 2022, Million Units
TABLE 76 France Antiplatelet Market, 2023 - 2030, Million Units
TABLE 77 France Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 78 France Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 79 France Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 80 France Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 81 France Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 82 France Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 83 France Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 84 France Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 85 France Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 86 France Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 87 Russia Antiplatelet Market, 2019 - 2022, USD Million
TABLE 88 Russia Antiplatelet Market, 2023 - 2030, USD Million
TABLE 89 Russia Antiplatelet Market, 2019 - 2022, Million Units
TABLE 90 Russia Antiplatelet Market, 2023 - 2030, Million Units
TABLE 91 Russia Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 92 Russia Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 93 Russia Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 94 Russia Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 95 Russia Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 96 Russia Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 97 Russia Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 98 Russia Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 99 Russia Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 100 Russia Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 101 Spain Antiplatelet Market, 2019 - 2022, USD Million
TABLE 102 Spain Antiplatelet Market, 2023 - 2030, USD Million
TABLE 103 Spain Antiplatelet Market, 2019 - 2022, Million Units
TABLE 104 Spain Antiplatelet Market, 2023 - 2030, Million Units
TABLE 105 Spain Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 106 Spain Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 107 Spain Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 108 Spain Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 109 Spain Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 110 Spain Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 111 Spain Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 112 Spain Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 113 Spain Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 114 Spain Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 115 Italy Antiplatelet Market, 2019 - 2022, USD Million
TABLE 116 Italy Antiplatelet Market, 2023 - 2030, USD Million
TABLE 117 Italy Antiplatelet Market, 2019 - 2022, Million Units
TABLE 118 Italy Antiplatelet Market, 2023 - 2030, Million Units
TABLE 119 Italy Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 120 Italy Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 121 Italy Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 122 Italy Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 123 Italy Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 124 Italy Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 125 Italy Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 126 Italy Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 127 Italy Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 128 Italy Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 129 Rest of Europe Antiplatelet Market, 2019 - 2022, USD Million
TABLE 130 Rest of Europe Antiplatelet Market, 2023 - 2030, USD Million
TABLE 131 Rest of Europe Antiplatelet Market, 2019 - 2022, Million Units
TABLE 132 Rest of Europe Antiplatelet Market, 2023 - 2030, Million Units
TABLE 133 Rest of Europe Antiplatelet Market by Route of Administration, 2019 - 2022, USD Million
TABLE 134 Rest of Europe Antiplatelet Market by Route of Administration, 2023 - 2030, USD Million
TABLE 135 Rest of Europe Antiplatelet Market by Route of Administration, 2019 - 2022, Million Units
TABLE 136 Rest of Europe Antiplatelet Market by Route of Administration, 2023 - 2030, Million Units
TABLE 137 Rest of Europe Antiplatelet Market by Drug Class, 2019 - 2022, USD Million
TABLE 138 Rest of Europe Antiplatelet Market by Drug Class, 2023 - 2030, USD Million
TABLE 139 Rest of Europe Antiplatelet Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 140 Rest of Europe Antiplatelet Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 141 Rest of Europe Antiplatelet Market by Distribution Channel, 2019 - 2022, Million Units
TABLE 142 Rest of Europe Antiplatelet Market by Distribution Channel, 2023 - 2030, Million Units
TABLE 143 Key Information – Cipla Limited
TABLE 144 Key Information – Glenmark Pharmaceuticals Limited
TABLE 145 Key Information – Bayer AG
TABLE 146 KEY INFORMATION – AstraZeneca PLC
TABLE 147 Key Information – Daiichi Sankyo Company, Limited
TABLE 148 Key Information – Eli Lilly And Company
TABLE 149 key information – Otsuka Pharmaceutical Co., Ltd.
TABLE 150 Key Information – Sanofi S.A.
TABLE 151 Key Information – Lupin Limited
TABLE 152 Key Information – Chiesi Farmaceutici S.p.A

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Antiplatelet Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Antiplatelet Market
FIG 4 Porter’s Five Force Analysis: Antiplatelet Market
FIG 5 Europe Antiplatelet Market share by Route of Administration, 2022
FIG 6 Europe Antiplatelet Market share by Route of Administration, 2030
FIG 7 Europe Antiplatelet Market by Route of Administration, 2019 - 2030, USD Million
FIG 8 Europe Antiplatelet Market share by Drug Class, 2022
FIG 9 Europe Antiplatelet Market share by Drug Class, 2030
FIG 10 Europe Antiplatelet Market by Drug Class, 2019 - 2030, USD Million
FIG 11 Europe Antiplatelet Market share by Distribution Channel, 2022
FIG 12 Europe Antiplatelet Market share by Distribution Channel, 2030
FIG 13 Europe Antiplatelet Market by Distribution Channel, 2019 - 2030, USD Million
FIG 14 Europe Antiplatelet Market share by Country, 2022
FIG 15 Europe Antiplatelet Market share by Country, 2030
FIG 16 Europe Antiplatelet Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Cipla Limited
FIG 18 SWOT Analysis: Glenmark Pharmaceuticals Limited
FIG 19 Swot Analysis: Bayer AG
FIG 20 SWOT Analysis: AstraZeneca PLC
FIG 21 SWOT Analysis: Daiichi Sankyo Company, Limited
FIG 22 Swot Analysis: Eli Lilly And Company
FIG 23 Swot Analysis: Otsuka Pharmaceutical Co., Ltd.
FIG 24 Swot Analysis: Sanofi S.A.
FIG 25 SWOT Analysis: Lupin Limited
FIG 26 SWOT Analysis: Chiesi Farmaceutici S.p.A